Date: Thursday, June 8, 2017
Session Time: 1:15pm-2:45pm
Location: Exhibit Hall C
To report seven clinical cases of treatment completion and improvement of symptoms after a PD therapy regimen that included Hepad.
DOPA decarboxylase inhibitor and dopamine supplements are widely prescribed to patients with Parkinson’s disease (PD). However, these drugs simply relieve PD symptoms temporarily, and may be associated with severe side effects such as dyskinesia. Moreover, they cannot cure or arrest the progress of PD. HEaling herbmedicine of PArkinson’s Disease (Hepad) is a herbal medicine with a formulation based on Korean medicinal theory, and has been prescribed to PD patients in Korean medical clinics.
Hepad was prescribed to seven patients who were diagnosed with PD. Conventional PD medical treatment was accompanied by Hepad therapy in five patients; the other two were treated with Hepad only. Hepad was administered one to three times per day, and the daily dose was reduced gradually.
Four of the five patients who received Hepad as an adjunct to conventional PD medicine discontinued medical treatment because of an improvement in PD symptoms within three to nine months, which was followed by Hepad-only therapy for two to fourteen months. The remaining patient stopped receiving conventional treatment and is taking Hepad only, and is experiencing ameliorated symptoms. Therapy was terminated in Hepad-only treated patients because of decreased symptoms of tremor and malaise.
The clinical cases in this study suggest that Hepad, which is based on Korean medicinal theory, is effective in PD patients either exclusively or as an adjunct to conventional PD medicines. Hepad treatment may resolve some of the limitations of conventional PD treatment and offer novel therapeutic opportunities in PD.
To cite this abstract in AMA style:D.H. Kim, D.H. Kim, J.J. Choi, B.J. Park. Medical Treatment Termination in Parkinson’s Disease Patients after Hepad Therapy: A Case Series [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/medical-treatment-termination-in-parkinsons-disease-patients-after-hepad-therapy-a-case-series/. Accessed March 1, 2024.
« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/medical-treatment-termination-in-parkinsons-disease-patients-after-hepad-therapy-a-case-series/